O-Sulfated Bacterial Polysaccharides with Low Anticoagulant Activity Inhibit Metastasis

ABSTRACT

Heparin-like polysaccharides possess the capacity to inhibit cancer cell proliferation, angiogenesis, heparanase-mediated cancer cell invasion, and cancer cell adhesion to vascular endothelia via adhesion receptors, such as selectins. The clinical applicability of the antitumor effect of such polysaccharides, however, is compromised by their anticoagulant activity. We have compared the potential of chemically O-sulfated and N,O-sulfated bacterial polysaccharide (capsular polysaccharide from E. coli K5 [K5PS]) species to inhibit metastasis of mouse B16-BL6 melanoma cells and human MDA-MB-231 breast cancer cells in two in vivo models. We demonstrate that in both settings, O-sulfated K5PS was a potent inhibitor of metastasis. Reducing the molecular weight of the polysaccharide, however, resulted in lower antimetastatic capacity. Furthermore, we show that O-sulfated K5PS efficiently inhibited the invasion of B16-BL6 cells through Matrigel and also inhibited the in vitro activity of heparanase. Moreover, treatment with O-sulfated K5PS lowered the ability of B16-BL6 cells to adhere to endothelial cells, intercellular adhesion molecule-1, and P-selectin, but not to E-selectin. Importantly, O-sulfated K5PSs were largely devoid of anticoagulant activity. These findings indicate that O-sulfated K5PS polysaccharide should be considered as a potential antimetastatic agent.

KEYWORDS

K5 polysaccharide - heparin - cancer - metastasis - anticoagulation

REFERENCES

• 1 Zacharski L R, Ornstein D L. Heparin and cancer.  Thromb Haemost. 1998;  80 10-23
• 2 Hejna M, Radarer M, Zielinski C. Inhibition of metastases by anticoagulants.  J Natl Cancer Inst. 1999;  91 22-36
• 3 Smörenburg S M, Van Noorden C JF. The complex effects of heparins on cancer progression and metastasis in experimental studies.  Pharmacol Rev. 2001;  53 93-105
• 4 Irimura T, Nakajima M, Nicolson G L. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.  Biochemistry. 1986;  25 5322-5328
• 5 Vlodavsky I, Mohsen M, Lider O et al.. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.  Invasion Metastasis. 1994;  14 290-302
• 6 Lundin L, Larsson H, Kreuger J et al.. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.  J Biol Chem. 2000;  275 24653-24660
• 7 Miao H Q, Elkin M, Aingorn E, Ishai-Michaeli R, Stein C A, Vlodavsky I. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides.  Int J Cancer. 1999;  83 424-431
• 8 Kaeffer B, Benard C, Lahaye M, Blottiere H M, Cherbut C. Biological properties of ulvan, a new source of green seaweed sulfated polysaccharides, on cultured normal and cancerous solonic epithelial cells.  Planta Med. 1999;  65 527-531
• 9 Wellstein A, Zugmaier G, Califano 3rd J A, Kern F, Paik S, Lippman M E. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate.  J Natl Cancer Inst. 1991;  83 716-720
• 10 Zugmaier G, Lippman M E, Wellstein A. Inhibition by pentosan polysulfate (PPS) of heparin binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals.  J Natl Cancer Inst. 1992;  84 1716-1724
• 11 Rosenthal M A, Rischin D, McArthur G et al.. Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia.  Ann Oncol. 2002;  13 770-776
• 12 Yu G, Gunay N S, Lindhardt R J et al.. Preparation and anticoagulant activity of the phosphosulfomannan PI-88.  Eur J Med Chem. 2002;  37 783-791
• 13 Vann W F, Schmidt M A, Jann B, Jann K. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin.  Eur J Biochem. 1981;  116 359-364
• 14 Borgenström M, Jalkanen M, Salmivirta M. Sulfated derivatives of Escherichia coli K5 polysaccharides as modulators of fibroblast growth factor signaling.  J Biol Chem. 2003;  278 49882-49889
• 15 Leali D, Belleri M, Urbinati C et al.. Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives.  J Biol Chem. 2001;  276 37900-37908
• 16 Presta M, Oreste P, Zoppetti G et al.. Antiangiogenic activity of semisynthetic biotechnological heparins.  Arterioscler Thromb Vasc Biol. 2005;  25 71-76
• 17 Poggi A, Rossi C, Casella N et al.. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.  Semin Thromb Hemost. 2002;  28 383-391
• 18 Vicenzi E, Gatti A, Ghessi S, Oreste P, Zoppetti G, Poli G. Broad spectrum inhibition of HIV-1 infection by sulphated K5 Escherichia coli polysaccharide derivatives.  AIDS. 2003;  17 177-181
• 19 Casu B, Grazioli G, Razi N et al.. Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5.  Carbohydr Res. 1994;  263 271-284
• 20 Guerrini M, Naggi A, Guglieri S, Santarsiero R, Torri G. Complex glycosaminoglycans: profilino substitution patterns by two dimensional NMR spectroscopy.  Anal Biochem. 2005;  337 35-47
• 21 Ise Y, Yamaguchi K, Sato K et al.. Molecular mechanisms underlying lymphocyte recirculation. I. Functional, phenotypical and morphological characterization of high endothelial cells cultured in vitro.  Eur J Immunol. 1988;  18 1235-1244
• 22 Arguello F, Baggs R B, Frantz C N. A murine model of experimental metastasis to bone and bone marrow.  Cancer Res. 1988;  48 6876-6881
• 23 Guise T A, Yin J J, Taylor S D et al.. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.  J Clin Invest. 1996;  98 1544-1549
• 24 Naggi A, Casu B, Perez M et al.. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.  J Biol Chem. 2005;  280 12103-12113
• 25 Nakajima M, Irimuta T, Di Ferrante N, Nicolson G L. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucoronidase.  J Biol Chem. 1984;  259 2283-2290
• 26 Fidler I J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine.  J Natl Cancer Inst. 1970;  45 773-782
• 27 Pikas D S, Li J P, Vlodavsky I, Lindahl U. Substrate specificity of heparanases from human hepatoma and platelets.  J Biol Chem. 1998;  273 18770-18777
• 28 Lever R, Hoult R S, Page C P. The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro.  Br J Pharmacol. 2000;  129 533-540
• 29 Nelson R M, Cecconi O, Roberts G, Aruffo A, Lindhardt R J, Bevilacqua M P. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation.  Blood. 1993;  82 3253-3258
• 30 Koenig A, Norgard-Sumnicht K, Lindhardt R, Varki A. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins.  J Clin Invest. 1998;  101 877-889
• 31 Ma Y-Q, Geng J-G. Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 Cells to P-selectin under flow.  J Immunol. 2000;  165 558-565
• 32 Borsig L, Wong R, Feramisco J, Nadeau D R, Varki N M, Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.  Proc Natl Acad Sci USA. 2001;  98 3352-3357
• 33 Wei M, Tai G, Gao Y et al.. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions.  J Biol Chem. 2004;  279 29202-29210
• 34 Nieswandt B, Hafner M, Echtenacher B, Mannel D N. Lysis of tumor cells by natural killer cells in mice is impeded by platelets.  Cancer Res. 1999;  59 1295-1300
• 35 Karpatkin S, Pearlstein E, Ambrogio C, Coller B S. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo.  J Clin Invest. 1988;  81 1012-1019